Sonnet BioTherapeutics Holdings, Inc.Sonnet BioTherapeutics Holdings, Inc.Sonnet BioTherapeutics Holdings, Inc.

Sonnet BioTherapeutics Holdings, Inc.

No trades
See on Supercharts

Price target

20.000.000.00%
The 1 analyst offering 1 year price forecasts for SONN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings to SONN in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


SONN EPS for the last quarter is −3.83 USD despite the estimation of −5.52 USD. In the next quarter EPS is expected to reach −1.39 USD. Track more of Sonnet BioTherapeutics Holdings, Inc. financials and stay on top of what is up with the company.
In the next quarter Sonnet BioTherapeutics Holdings, Inc. revenue is expected to reach 0.00 USD. Check out Sonnet BioTherapeutics Holdings, Inc. revenue and earnings and make informed decisions.
According to analysts, SONN price target is 20.00 USD with a max estimate of 20.00 USD and a min estimate of 20.00 USD. Check if this forecast comes true in a year, meanwhile watch Sonnet BioTherapeutics Holdings, Inc. stock price chart and keep track of the current situation with SONN news and stock market news.